Liver resection for hepatocellular carcinoma in a hepatitis B endemic area

World Journal of Surgery

Volumn 31, Issue 9, 2007, Pages 1775-1781

  Bartlett, Adam St J R ^a   McCall, John L ^a   Koea, Jonathan B ^a   Holden, Andrew ^a   Yeong, Mee Ling ^a   Gurusinghe, Nishanthi ^a   Gane, Ed ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC HEPATITIS; DISEASE FREE SURVIVAL; ENDEMIC DISEASE; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PARTIAL HEPATECTOMY; POSTOPERATIVE PERIOD; RECURRENT DISEASE; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CHILD; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEW ZEALAND; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34548012826     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9069-4     Document Type: Article

References (37)

1. Marui Y, McCall J, Gane E, et al. (2005) Liver transplantation for hepatocellular carcinoma in New Zealand: a prospective intent-to-treat analysis. N Z Med J 118:U1532
2. Sutcliffe R, Maguire D, Portmann B, et al. (2006) Selection of patients with hepatocellular carcinoma for liver transplantation. Br J Surg 93:11-18
3. Chen M-S, Li J-Q, Zheng Y, et al. (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatcellular carcinoma. Ann Surg 243:321-328
4. Llovet JM, Fuster J, Bruix J (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30:1434-1440
5. Fong Y, Sun RL, Jarnagin W, et al. (1999) An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg 229:790-799
6. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362:1907-1917
7. Fung J, Gane E, Bullen C, et al. (2004) Improved survival with screening for hepatocellular carcinoma in chronic hepatitis B: preliminary results of a national surveillance programme. Hepatology 40(Suppl 1):258A
8. Majno P, Mentha G, Mazzaferro V (2005) Resection, transplantation, either, or both? Other pieces of the puzzle. Liver Transpl 11:1177-1180
9. Pugh RN, Murray-Lyon IM, Dawson JL, et al. (1973) Transection of the oesophagus for bleeding oesophageal varicies. Br J Surg 60:646-649
10. Pang YY, Strasberg S (2000) The Brisbane 2000 Terminology of Liver Anatomy and Resections. HPB 2:333-339
11. McCall JL, Koea J, Gunn K, et al. (2001) Liver resections in Auckland 1998-2001: mortality, morbidity and blood product use. N Z Med J 114:516-519
12. Ishak K, Baptista A, Bianchi L, et al. (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696-699
13. Edmondson HA, Steiner DE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462-503
14. Greene F, Page DL, Fleming ID, et al. (2002) American Joint Committee of Cancer (AJCC) Cancer Staging Manual 2002. Chicago, Springer
15. Investigators (2000) Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 31:840-845
16. Chiappa A, Zbar AP, Audisio RA, et al. (2000) Factors affecting survival and long-term outcome in the cirrhotic patient undergoing hepatic resection for hepatocellular carcinoma. Eur J Surg Oncol 26:387-392
17. Abdalla EK, Barnett CC, Doherty D, et al. (2002) Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolisation. Arch Surg 137:675-681
18. Farges O, Belghiti J, Kianmanesh R, et al. (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann. Surg 237:208-217
19. Hemming A, Scudamore C, Shackleton CR, et al. (1992) Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 163:515-518
20. Lam C, Fan ST, Lo CM, et al. (1999) Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg 86:1012-1017
21. Fuster J, Garcia-Valdecasas J, Grande L, et al. (1996) Hepatocellular carcinoma and cirrhosis: results of surgical treatment in a European series. Ann Surg 223:297-302
22. Ercolani G, Grazi G, Ravaioli M, et al. (2003) Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg 237:536-543
23. Lang H, Sotiropoulos G, Domland M, et al. (2005) Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis. B J Surg 92:198-202
24. Kanematsu T, Furui J, Yanaga K, et al. (2002) A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985-2000. Surgery 131:S153-S158
25. Lau WY, Leung TW, Ho SK, et al. (1999) Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet 353:797-801
26. Boucher E, Corbinais S, Rolland Y, et al. (2003) Adjuvant intra-arterial injection of iodine-131 labelled lipiodol after resection of hepatocellular carcinoma. Hepatology 38:1237-1241
27. Belghiti J, Cortes A, Abdalla EK, et al. (2004) Resection prior to transplantation for hepatocellular carcinoma. Ann Surg 238:885-893
28. Adam R, Azoulay D (2005) Is primary resection and salvage transplantation for hepatocellular carcinoma: a reasonable strategy [comment]? Ann Surg 241:671-672
29. Ohkubo T, Yamamoto J, Sugawara Y, et al. (2000) Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg 191:657-660
30. Burns J, Greene F (2005) Controversies in staging of hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 12:456-462
31. Investigators (1998) A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 28:751-755
32. Levy I, Sherman M (2002) Staging of hepatocellular carcinoma: assessment of the CLIP, Okunda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 50:881-885
33. Rugge J, Lochner L, Judkins D (2006) What is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B? J Family Practice 55:155-156
34. De Masi S, Tosti ME, Mele A (2005) Screening for hepatocellular carcinoma. Dig Liver Dis 37:260-268
35. Kemp W, Pianko S, Nguyen S, et al. (2005) Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease. J Gastroenterol Hepatol 20:873-881
36. Wyn Y, Dickinson J (2003) Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B. Cochrane Database of Systematic Reviews (CD002799)
37. Zhang B, Yang B, Tang Z (2004) Randomised controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130:417-422